ММВБ 3 811 -3,5%  Nasdaq 15 492 -2,2%  Биткойн 54 133 -0,9%  USD/RUB 75,5595 -0,1% 
РТС 1 589 -4,6%  S&P500 4 595 -2,3%  Нефть 72,9 -11,4%  EUR/RUB 85,5400 0,0% 
Dow 34 899 -2,5%  FTSE100 7 044 -3,6%  Золото 1 793 0,2%  EUR/USD 1,1320 1,0% 

Zynerba Pharmaceuticals Inc - Профиль

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.

Акционеры

Название Доля (%)
Freefloat97,04
ETF Managers Group LLC11,18
ETF Managers Group LLC10,82
Vanguard Group, Inc. (Subfiler)4,45
The Vanguard Group, Inc.3,52
D.E. Shaw & Co., Inc.3,41
AdvisorShares Trust Pure US Cannabis ETF3,05
Global X Management Co. LLC2,60
Ikarian Capital LLC2,59
BlackRock Institutional Trust Co. NA1,70
Armando Anido, MBA1,47
Prentice Capital Management LP1,33
Millennium Management LLC0,94
Penserra Capital Management LLC0,92
Renaissance Technologies LLC0,87

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент